IC
RVMD icon

IEQ Capital’s Revolution Medicines RVMD Stock Holding History

IEQ Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.51M Sell
36,113
-11,299
-24% -$1.14M 0.02% 589
2025
Q4 		$3.78M Buy
47,412
+41,912
+762% +$2.75M 0.01% 602
2025
Q3 		$257K Buy
+5,500
New +$215K ﹤0.01% 1584
2025
Q1 		– Sell
-4,700
Closed -$206K – 1713
2024
Q4 		$206K Hold
4,700
– – ﹤0.01% 1199
2024
Q3 		$213K Buy
+4,700
New +$205K ﹤0.01% 1045

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IEQ Capital's RVMD Position: Q1 2026 in Review

IEQ Capital reduced its Revolution Medicines (RVMD) stake by 24% in Q1 2026, selling an estimated $1.14M and leaving 36,113 shares worth $3.51M. The position accounts for 0.02% of the portfolio, ranked #589.

IEQ Capital first reported a position in RVMD in Q3 2024 and has held it in 5 quarters since. The position peaked at $3.78M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • IEQ Capital held 36,113 shares of Revolution Medicines worth $3.51M as of Q1 2026.
  • IEQ Capital sold 11,299 Revolution Medicines shares in Q1 2026, an estimated $1.14M.
  • Revolution Medicines made up 0.02% of IEQ Capital's portfolio in Q1 2026, its #589 holding.
  • IEQ Capital first reported a position in Revolution Medicines in Q3 2024 and has held it in 5 quarters since.
  • IEQ Capital's Revolution Medicines position peaked at $3.78M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.